Advisor Group’s Novo Nordisk NVO Stock Holding History

Advisor Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.97M	Buy	67,962 +3,588	+6%	+$99.3K	0.01%	820
2019 Q3	$1.67M	Sell	64,374 -1,938	-3%	-$49K	0.01%	841
2019 Q2	$1.69M	Sell	66,312 -10,950	-14%	-$271K	0.01%	830
2019 Q1	$2.02M	Sell	77,262 -34,016	-31%	-$836K	0.02%	715
2018 Q4	$2.56M	Buy	111,278 +16,994	+18%	+$378K	0.03%	538
2018 Q3	$2.22M	Buy	94,284 +19,208	+26%	+$469K	0.02%	602
2018 Q2	$1.73M	Sell	75,076 -7,638	-9%	-$182K	0.02%	602
2018 Q1	$2.04M	Sell	82,714 -46,806	-36%	-$1.23M	0.03%	556
2017 Q4	$3.48M	Buy	129,520 +914	+0.7%	+$23.2K	0.05%	358
2017 Q3	$3.1M	Sell	128,606 -940	-0.7%	-$21.2K	0.05%	356
2017 Q2	$2.78M	Sell	129,546 -5,272	-4%	-$106K	0.05%	372
2017 Q1	$2.31M	Sell	134,818 -13,988	-9%	-$244K	0.05%	407
2016 Q4	$2.67M	Sell	148,806 -47,468	-24%	-$861K	0.06%	339
2016 Q3	$4.08M	Sell	196,274 -1,196	-0.6%	-$29.7K	0.1%	225
2016 Q2	$5.31M	Buy	+197,470	New	+$5.42M	0.14%	165

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Advisor Group's NVO Position: Q4 2019 in Review

Advisor Group increased its Novo Nordisk (NVO) stake by 5.6% in Q4 2019, buying an estimated $99.3K and bringing the position to 67,962 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #820.

Advisor Group first reported a position in NVO in Q2 2016 and has held it in 15 quarters since. The position peaked at $5.31M in Q2 2016. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

Advisor Group held 67,962 shares of Novo Nordisk worth $1.97M as of Q4 2019.
Advisor Group bought 3,588 Novo Nordisk shares in Q4 2019, an estimated $99.3K.
Novo Nordisk made up 0.01% of Advisor Group's portfolio in Q4 2019, its #820 holding.
Advisor Group first reported a position in Novo Nordisk in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Novo Nordisk position peaked at $5.31M in Q2 2016.
640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.